Global antimicrobial resistance: from surveillance to stewardship. Part 2: Stewardship initiatives

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 12, 2012, Pages 1375-1377

  Cantón, Rafael ^a   Bryan, Jenny ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE

Author keywords

antimicrobial resistance; antimicrobial stewardship; Gram negative organisms; resistance surveillance

Indexed keywords

ANTIBIOTIC AGENT; AVIBACTAM; BAL 30072; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTAROLINE; CEFTAZIDIME; CEFTOLOZANE; CIPROFLOXACIN; ERAVACYCLINE; ME 1071; METALLO BETA LACTAMASE; METICILLIN; PLAZOMICIN; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASYMPTOMATIC BACTERIURIA; CERTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; DISEASE SURVEILLANCE; DRUG POTENTIATION; DRUG RESEARCH; DRUG USE; EUROPE; FEEDBACK SYSTEM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH PROGRAM; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL AUDIT; MEDICAL DECISION MAKING; MEDICAL LEAVE; MEDICAL SOCIETY; MEDICATION ERROR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHRITIS; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PSEUDOMONAS AERUGINOSA; SINUSITIS; SORE THROAT; STAFF TRAINING; TREATMENT DURATION; UNITED KINGDOM; URINARY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84871411286     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.140     Document Type: Conference Paper

References (14)

1. Howard P, Pulcini C, Nathwani D, Levy-Hara G, Gould I. Development of a Worldwide Antimicrobial Stewardship Survey. Presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).London, UK, 31 MarchY3 April 2012 (Poster 1059).
2. Cook PP, Rizzo S, Gooch M, Jordan M, Fang X, Hudson S. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. J. Antimicrob. Chemother. 66(1), 205-209 (2011).
3. Wickens HJ, Ashiru-Oredope DAI, Farrell S, Jacklin A, Holmes A. Managing and reporting of antibiotic usage data in English hospitals. Clin. Microbiol. Infect. 18(Suppl. S3), 108(O658) (2012).
4. Dumartin C, Rogues A-M, L'Heriteau F et al. Antibiotic policies in 36 French intensive care units in 2010: Which measures to control consumption? Clin. Microbiol. Infect. 18(Suppl. S3), 109(O659) (2012).
5. Vaghela T, Parida S, Singh P. Optimising antimicrobial use: Outcome of IV antimicrobial rounds as part of an Antimicrobial Stewardship Programme at a large district general hospital in east of England. Clin. Microbiol. Infect. 18(Suppl. S3), 107(O656) (2012).
6. Fleet E, Gopal Rao G, Patel B et al. Randomised control study of antibiotic use in nursing/care homes: Initial findings. Clin. Microbiol. Infect. 18(Suppl. S3), 109(O660) (2012).
7. Martin M, Murillas J, Campins A et al. Adherence to recommendations of an Antimicrobial Stewardship Programme. Presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).London, UK, 31 MarchY3 April 2012 (Poster 1054).
8. Katsarolis I, Antoniadou A, Poulakou G et al. Antibiotic prescribing habits in primary care adult respiratory tract infections. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O281) (2012).
9. Denes E, Prouzergue J, Ducroix-Roubertou S, Aupetit C, Weinbreck P. Analysis of antibiotic prescriptions done by general practitioners for urinary tract infections. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O283) (2012).
10. Cortoos PJ, Bochet M, Horbarth S, Gyssens IC. The possible effect of sickness regulation on volume of antibiotic consumption in 30 European countries. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O282) (2012).
11. Cantón R, Bryan J. Global antimicrobial resistance: From surveillance to stewardship. Part 1: Surveillance. Expert Rev. Anti Infec. Ther. 10(11), 1269-1271 (2012).
12. Ishii Y, Eto M, Mano Y, Tateda K, Yamaguchi K. In vitro potentiation of carbapenems with ME1071, a novel metallo-β-lactamase inhibitor, against metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 54(9), 3625-3629 (2010).
13. Zhanel GG, Lawson CD, Zelenitsky S et al. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Expert Rev. Anti. Infect. Ther. 10(4), 459-473 (2012).
14. Grossman TH, Starosta AL, Fyfe C et al. Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Antimicrob. Agents Chemother. 56(5), 2559-2564 (2012).